Risk factors and their relationship to prognosis in myelodysplastic syndromes.

[1]  T Hamblin,et al.  International scoring system for evaluating prognosis in myelodysplastic syndromes. , 1997, Blood.

[2]  C. Declercq,et al.  Prognostic factors in myelodysplastic syndromes: critical analysis of the impact of age and gender and failure to identify a very‐low‐risk group using standard mortality ratio techniques , 1996, British journal of haematology.

[3]  C. Barton,et al.  t(8;21) myelodysplasia, an early presentation of M2 AML , 1995, British journal of haematology.

[4]  E. Estey,et al.  Clinical and prognostic significance of trisomy 21 in adult patients with acute myelogenous leukemia and myelodysplastic syndromes. , 1995, Leukemia.

[5]  E. Estey,et al.  Abnormalities in the long arm of chromosome 11 (11q) in patients with de novo and secondary acute myelogenous leukemias and myelodysplastic syndromes. , 1994, Leukemia.

[6]  H. Gralnick,et al.  The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia: Proposals by the French ‐ American ‐ British Cooperative Leukaemia Group , 1994, British journal of haematology.

[7]  O. Garson,et al.  The prognostic significance of deletion of the long arm of chromosome 20 in myeloid disorders. , 1994, Leukemia.

[8]  E. Wattel,et al.  De novo myelodysplastic syndrome (MDS) with deletion of the long arm of chromosome 20: a subtype of MDS with distinct hematological and prognostic features? , 1993, Leukemia research.

[9]  A. Duhamel,et al.  Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. , 1993, Leukemia.

[10]  S. Asano,et al.  Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan. , 1993, Leukemia.

[11]  F. Solé,et al.  Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes. , 1992, Cancer genetics and cytogenetics.

[12]  K. United.  Loss of the Y chromosome from normal and neoplastic bone marrows , 1992, Genes, chromosomes & cancer.

[13]  U. Germing,et al.  Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system. , 1992, Leukemia.

[14]  D. Hossfeld,et al.  Results of chromosome studies and their relation to morphology, course, and prognosis in 120 patients with de novo myelodysplastic syndrome. , 1990, Cancer genetics and cytogenetics.

[15]  J. Rowley,et al.  Clinical-cytogenetic correlations in myelodysplasia (preleukemia). , 1989, Cancer genetics and cytogenetics.

[16]  M. Sanz,et al.  Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. , 1989, Blood.

[17]  R. Larson,et al.  Specific chromosomal abnormalities in acute nonlymphocytic leukemia correlate with drug susceptibility in vivo. , 1988, Leukemia.

[18]  M. Oken,et al.  Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia , 1988, British journal of haematology.

[19]  F. Sigaux,et al.  Cytogenetic studies on 519 consecutive de novo acute nonlymphocytic leukemias. , 1987, Cancer genetics and cytogenetics.

[20]  D. Oscier.  5 Myelodysplastic syndromes , 1987 .

[21]  G. Borgström.  Cytogenetics of the myelodysplastic syndromes. , 2009, Scandinavian journal of haematology. Supplementum.

[22]  J. Rowley,et al.  Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes , 1986 .

[23]  S. Nakazawa,et al.  Clinical and hematologic characteristics in acute leukemia with 11q23 translocations. , 1986, Blood.

[24]  G. Tricot,et al.  The 5q-anomaly. , 1985, Cancer genetics and cytogenetics.

[25]  D. Machin,et al.  Myelodysplastic syndromes: a scoring system with prognostic significance , 1985, British journal of haematology.

[26]  H. Gralnick,et al.  Proposals for the classification of the myelodysplastic syndromes , 1982, British journal of haematology.

[27]  Iscn.  International System for Human Cytogenetic Nomenclature , 1978 .

[28]  H. Berghe,et al.  A new hematologic syndrome with a distinct karyotype: the 5 q--chromosome. , 1975, Blood.